Premenstrual syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: Control group: placebo capsules 2 times a day (2 tablets every 12 hours) for 7 days prior to the first day of the menstrual cycle. Intervention 2: Soft capsules containing 20 mg of ess
Treatment - Drugs
Control group: placebo capsules 2 times a day (2 tablets every 12 hours) for 7 days prior to the first day of the menstrual cycle
Soft capsules containing 20 mg of essential oil and 2 times a day (every 12 hours 2 tablets) for 7 days prior to the first day of the menstrual cycle
Sponsors
Vice chancellor for research, Kashan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Age range of 18-35 years; a mark of at least 5 of the questionnaire to detect symptoms of temporary Pms; that at least one of the five symptoms of psychiatric symptoms and the severity of each offense included within the average or more during the past two months ; having a regular menstrual cycle; lack of stressor during the previous 3 months; lack of physical illness and mental; Non-hormonal medications and anti depressants. Exclusion criteria: Persons who during the study Getting sick; being hospitalized;being pregnant; the reading experience of be stressful; those who do not use the medicine properly; or do not complete the form correctly.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of premenstrual syndrome. Timepoint: 2 months before the study, 2 months after the intervention. Method of measurement: Daily chart position. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMarzieh Sodouri
Kashan University of Medical Sciences
Outcome results
None listed